Share Options5 Apr 2026 20:07
The accounting entry cost of £753k relating to share options is due to the Directors options and 5,250,000 to employees
S P O’Hara -3,000,000 0.210
M Caspani - -500,000 0.210
A Reynolds - 1,000,000 0.210
S Andersen - 5,000,000 0.095
The share options held by S P O’Hara, and A Reynolds were granted on 31 March 2022 and are exercisable at £0.21 at any time up 30 March 2032, 50% of which vest on a doubling of the share price to £0.42 and 50% on an annual turnover of £2.5m.
The share options held by M Caspani were granted on 31 March 2022 and are exercisable at £0.21 at any time up 30 March 2032, 1/3 of which vest on each of the 2-4 anniversaries of the date of grant.
The share options held by S Andersen were granted on 10 February 2025 and are exercisable at £0.095 at any time up 18 February 2035 50% vest when annual turnover reaches £2.5m, 50% vest on annual turnover of £5m.
so turnover of £2.5m achieved therefore a number have vested - though obviously won't be exercised yet at our current sp
in addition to the above employees have 5,250,000 options which basically vest again at £2.5m and £5m turnover and 9.5p
5,000,000 options vest as to 50% on a doubling of the share price to £0.42 and 50% on an annual turnover of £2.5m;
500,000 options, 1/3 of which vest on each of the 2-4 anniversaries of the date of grant; and
9,250,000 options vest as to 50% on an annual turnover of £2.5m and 50% on an annual turnover of £5m
now 20 Feb 2025 rns
ProBiotix Health plc (AQSE: PBX), the life sciences business developing probiotics to support cardiometabolic health, announces that options ("Options") have been granted over a total of 9,050,000 ordinary shares of 0.05p each in the Company ("Ordinary Shares") to Steen Andersen, Chief Executive of ProBiotix, and certain other key employees of the Company.
The options were granted on 19 February 2025 with an exercise price of 9.5p per share. The Options may be exercised within 10 years from the date of their grant, subject to satisfaction of commercially oriented performance criteria, which includes significant revenue targets.
Option holders can only exercise Options once these conditions have been met. This ensures a continued focus on commercial revenues and shareholder value creation.
apparently 2.5m and 5m are significant revenue targets!
similar to rns 13 oct with 700,000 granted to employees
Must be one of the easiest targets to reach and a vesting price under 50% of original issue price
jees
mol
Sign In
Follow the stocks
